Studies demonstrate protection against diabetes, obesity, cardiovascular disease, kidney disease, liver disease, neurodegeneration, and cancer through comprehensive metabolic optimization
The defining 2018 Biochemical Pharmacology study reported a methylquinolinium NNMT inhibitor reducing body weight, white-fat mass and adipocyte size in diet-induced obese mice without changing food intake, while raising intracellular NAD+ and SAM [1]
These signs usually mean its time to schedule your next injection
Diabetes Studies have shown that those with Type 2 and Type 1 Diabetes have a higher tendency to have insufficient Vitamin B12 in their body
This slower, sustained absorption makes IM shots well suited for steady maintenance rather than acute correction
The hypothesis is that by inhibiting NNMT, 5-Amino-1MQ may help restore a more balanced metabolic state, potentially boosting levels of a critical coenzyme called NAD+ and reducing unhealthy fat accumulation [1]